Lynsey Devlin
0000-0002-4047-0686
3 papers found
Refreshing results…
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)
Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy
Missing publications? Search for publications with a matching author name.